Palliative thoracic radiotherapy in non-small cell lung cancer. An analysis of 1250 patients. Palliation of symptoms, tolerance and toxicity

Lung Cancer

Volumn 71, Issue 3, 2011, Pages 344-349

  Reinfuss, Marian ^a   Mucha Małecka, Anna ^a   Walasek, Tomasz ^a   Blecharz, Paweł ^a   Jakubowicz, Jerzy ^a   Skotnicki, Piotr ^a   Kowalska, Teresa ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Advanced NSCLC; Palliation of symptoms; Palliative thoracic radiotherapy; Tolerance; Toxicity

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; BRONCHODILATING AGENT; STEROID;

ADULT; ADVANCED CANCER; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DISEASE SEVERITY; DYSPHAGIA; DYSPNEA; ESOPHAGITIS; ESOPHAGOBRONCHIAL FISTULA; FEMALE; HEMOPTYSIS; HOARSENESS; HUMAN; LUNG FIBROSIS; LUNG HEMORRHAGE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; THORAX PAIN; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; RADIATION TOLERANCE;

EID: 79851508872     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.06.019     Document Type: Article

References (52)

1. Abratt R.P., Bogart J.A., Hunter A. Hypofractionated irradiation for non-small cell lung cancer. Lung Cancer 2002, 36:225-233.
2. Bomford C.K., Kunkler I.H., Hancock B.W. Walter and Miller's Textbook Of Radiotherapy 2003, Livingstone, pp. 426-427. 6th edn.
3. Collins T.M., Ash D.V., Close H.J., Thorogood J. An evaluation of the palliative role of radiotherapy in inoperable carcinoma of the bronchus. Clin Radiol 1988, 39:284-286.
4. Jassem J. The role of radiotherapy in lung cancer: where is evidence?. Radiother Oncol 2007, 83:203-213.
5. Kramer G.W., Wanders S.L., Noordijk E.M., Vonk E.J., Van Houwelingen H.C., Van den Hout W.B., et al. Results of the Dutch national study of the palliative effect of irradiation using two different treatment schemes for non-small cell lung cancer. J Clin Oncol 2005, 23:2962-2970.
6. Langendijk J.A., ten Velde G.P., Aaronson N.K., de Jong J.M., Muller M.J., Wouters E.F., et al. Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 2000, 47:149-155.
7. Macbeth F.R., Bolger J.J., Hopwood P., Bleehen N.M., Cartmell J., Girling D.J., et al. Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Clin Oncol 1996, 8:167-175.
8. Macbeth F.R., Abratt R.P., Cho K.H., Stephens R.J., Jeremic B International Atomic Energy Agency. Lung cancer management in limited resource settings: guidelines for appropriate good care. Radiother Oncol 2007, 82:123-131.
9. Medical Research Council Lung Cancer Working Party A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small cell lung cancer (NSCLC) and poor performance status. Br J Cancer 1992, 65:934-941.
10. Numico G., Russi E., Merlano M. Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?. Lung Cancer 2001, 32:213-226.
11. Plataniotis G.A., Kouvaris J.R., Dardoufas C., Pistevou-Gobaki K., Kouloulias V., Papadopoulos L.S., et al. A short radiotherapy course for locally advanced non-small cell lung cancer (NSCLC). Effective palliation and patients convenience. Lung Cancer 2002, 35:203-209.
12. Rees G.J., Devrell C.E., Barley V.L., Newman H.F. Palliative radiotherapy for lung cancer: two versus five fractions. Clin Oncol 1997, 9:90-95.
13. Reinfuss M., Skołyszewski J., Kowalska T., Rzepecki W., Kociołek D., et al. Palliative radiotherapy in asymptomatic patients with locally advanced, unresectable, non-small cell lung cancer. Strahlenther Onkol 1993, 12:709-715.
14. Reinfuss M., Gliński B., Kowalska T., Kulpa J., Zawiła K., Reinfuss K., et al. Radiotherapie du cancer bronchique non a petites cellules de stade III, inoperable, asymptomatique Resultats definitifs d'un essai prospectif randomise (240 patients). Cancer Radiother 1999, 3:475-479.
15. Simpson J.R., Francis M.E., Perez-Tamayo R., Marks R.D., Rao D.V. Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys 1985, 11:751-758.
16. Teo P., Tai T.H., Choy P., Tsiu K.H. A randomized study on palliative radiation therapy for inoperable non-small cell carcinoma of the lung. Int J Radiol Oncol Biol Phys 1988, 14:867-871.
17. Bezjak A., Dixon P., Brundage M., Tu D., Palmer M.J., Blood P., et al. Randomized study of single versus fractionated radiotherapy (RT) in the palliation of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 54:712-728.
18. Hoskin P.J. Palliative radiotherapy for non-small cell lung cancer: which dose?. Clin Oncol (R Coll Radiol) 2005, 17:59-60.
19. Medical Research Council Lung Cancer Working Party Inoperable non-small cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party. Br J Cancer 1991, 63:265-270.
20. Senkus-Konefka E., Dziadziuszko R., Bednaruk-Młyñski, Pliszka A., Kubrak J., Lewandowska A., et al. A prospective, randomized study to compare the value of two fractionation schedules of palliative radiotherapy for inoperable non-small cell lung cancer. Br J Cancer 2005, 92:1038-1045.
21. Sundstrom S., Bremnes R., Aasebo U., Aamdal S., Hatlevoll R., Brunsvig P., et al. Hypofractionated palliative radiotherapy (17Gy per two fractions) in advanced non-small cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial. J Clin Oncol 2004, 22:801-810.
22. American Joint Committee on cancer AJCC cancer staging manual 2002, Springer, New York, pp. 191-204. 6th edition.
23. Detterbeck F.C., Jones D.R., Morris D.E. Palliative treatment of lung cancer. Diagnosis and treatment of lung cancer 2001, 419-435. WB Saunders Corp, Philadelphia. F.C. Detterbeck, M.O. Rivera, M.A. Socinski, J.G. Rosenamnn (Eds.).
24. Sullivan F.J. Palliative radiotherapy for lung cancer. Lung cancer: principles and practice 1996, 775-789. Lippincott Raven, Philadelphia. H.I. Pass, J.B. Mitchell, D.H. Johnson, A.T. Turrisi (Eds.).
25. Sundstrom S., Bremnes R., Brunsvig P., Aasebo V., Olbjorn K., Fayers P.M., et al. Immediate or delayed radiotherapy in advanced non-small-cell lung cancer (NSCLC)? Data from a prospective randomised study. Radiother Oncol 2005, 75:141-148.
26. Efficace F., Bottomley A., Smit E.F., Lianes P., Legrand C., Debruyne C., et al. Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Ann Oncol 2006, 17:1698-1704.
27. Roswit B., Patno M.E., Rapp R., Veinbergs A., Feder B., Stuhlbarg J., et al. The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo. Radiology 1968, 90:688-696.
28. Slawson R.G., Scott R.H. Radiation therapy in bronchogenic carcinoma. Radiology 1979, 132:175-176.
29. Van Houtte P Cancer bronchique inoperable: quelle traitement et quelles possibilites therapeutique? Lecon de la derniere decennie. Cancer Radiother 1998, 1:63-69.
30. Abratt R.P., Sheperd L.J., Salton D.G. Palliative radiation for stage 3 non-small cell lung cancer - a prospective study of two moderately high dose regimens. Lung Cancer 1995, 13:137-143.
31. Erridge S.C., Gaze M.N., Price A., Kelly C.G., Kerr G.R., Cull A., et al. Symptom control and quality of life in people with lung cancer: a randomized trial of two palliative radiotherapy fractionation schedules. Clin Oncol (R Coll Radiol) 2005, 17:61-67.
32. Guthrie R.T., Ptacek J.J., Hass A.C. Comparative analysis of two regimens of split course radiation in carcinoma of the lung. Am J Roentgenol 1973, 117:605-608.
33. Johnson D.H., Einhorn L.H., Bartolucci A., Birch R., Omura G., Perez C.A., et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med 1990, 113:33-38.
34. National Cancer Institute Common Toxicity Criteria 1998, National Cancer Institute, Bethesda.
35. Nestle U., Nieder C., Walter K., Abel U., Ukena D., Sybrecht G.W., et al. A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60Gy: results of a randomized equivalence study. Int J Radiat Oncol Biol Phys 2000, 48:95-103.
36. Reinfuss M., Skoyszewski J., Korzeniowski S., Rzepecki W. Results of radiotherapy with curative intent in non-small cell lung cancer. An analysis of 130 patients. Strahlenther Onkol 1992, 10:573-578.
37. Sandler A.B., Buzaid A.C. Lung cancer: a review of current therapeutic modalities. Lung 1992, 170:249-265.
38. Duisters C., Beurskens H., Nijsten S. Palliative chest irradiation in sitting position in patients with bulky advanced lung cancer. Radiother Oncol 2006, 79:285-287.
39. Bindi M., Tucci E., Pepi F., Bellezza A., Pirtoli L. Changes in performance status in patients with pulmonary carcinoma treated with mono-fractionation radiotherapy once a week. G Italy Oncol 1990, 10:89-92.
40. Wagner H. Non-small cell lung cancer. Clinical radiation oncology 2007, 911-938. Churchill Livingstone, Philadelphia. L.L. Gunderson, J.E. Tepper (Eds.).
41. Falk S.J., Girling D.J., White R.J., Hopwood P., Harvey A., Qian W., et al. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-smal cell lung cancer and minimal thoracic symptoms: randomised controlled trial. Br Med J 2002, 325:465-468.
42. Lutz S.T., Huang D.T., Ferguson C.L., Kavanagh B.D., Tercilla O.F., Lu J., et al. A retrospective quality of life analysis using the Lung Cancer Symptom Scale in patients treated with palliative radiotherapy for advanced non-small cell lung cancer. Int J Radioth Oncol Biol Phys 1997, 37:117-122.
43. Toy E., Macbeth F., Coles B., Melville A., Eastwood A. Palliative thoracic radiotherapy for non-small-cell lung cancer; a systematic review. Am J Clin Oncol 2003, 26:112-120.
44. Laing A.H., Berry R.J., Newman C.R., Peto J. Treatment of inoperable carcinoma of bronchus. Lancet 1975, 13:1161-1164.
45. Ball D., Smith J., Bishop J., Olver I., Davis S., O'Brien P., et al. A phase III study of radiotherapy with and without continuous-infusion fluorouracil as palliation for non-small-cell lung cancer. Br J Cancer 1997, 75:690-697.
46. Rosenzweig K.E., Movsas B., Bradley J., Gewanter R.M., Gopal R.S., Komaki R.U., et al. ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent. J Am Coll Radiol 2009, 6:85-95.
47. Tang J.I., Shakespeare T.P., Lu J.J., Chan Y.H., Lee K.M., Wong L.C., et al. Patients preference for radiotherapy fractionation schedule in the palliation of symptomatic unresectable lung cancer. J Med Imaging Radiat Oncol 2008, 52:497-502.
48. Hansen H.H. Treatment of non-smal cell lung cancer. Lung cancer therapy annual 5 2006, 127:166-196. Informa Healthcare, UK.
49. Lester J.F., Macbeth F.R., Toy E., Coles B. Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database Syst Rev 2006, 4:CD002143.
50. Mackbeth F.R., Toy E., Coles B., et al. Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database Syst Rev 2002, 1:CD002143.
51. Fairchild A., Harris K., Barnes E., Wong R., Lutz S., Bezjak A., et al. Palliative thoracic radiotherapy for lung cancer: a systematic review. J Clin Oncol 2008, 26:4001-4011.
52. Wagner H Just enough palliation: radiation dose and outcome in patients with non-small-cell lung cancer. J Clin Oncol 2008, 26:3920-3922.